Get the latest news on Scancell Holdings stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on SCNLF performance

Latest Scancell Holdings Stock News | OTC:SCNLF | Benzinga

Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AACAY

AFFINITY BEVERAGE GROUP by Affinity Beverage Group, Inc.

ABVG

ACRGF

ACTG

ADAP

AIHS

AMCX

AMHD

AMRX

AOBC

APELY

ATVK

ATXDY

BIREF

BUDZ

BVTK

CEQXF

CGLDF

CHMI

COMM

CRXPF

CXXIF

DLTH

ECIFF

EMMA

ERIC

FARM

FUTURE FARM TECHNOLOGIES by Future Farm Technologies Inc.

FFRMF

FLXS

FNJN

FQVLF

FRAC

FTMR

FTSI

GBLEF

GGAL

GPOR

HEGIY

HEGLF

HGSH

HYAC

JETMF

JMHLY

LAIX

LDSYF

LFUGF

LFUGY

LOVE

LTRPA

LVGO

MMDM

MMLP

MODVF

NBLX

NDLS

NGPHF

NINE

NOSUF

OISHY

OVATF

PGHEF

PNBK

POLA

POTN

PXPP

RAIL

RRRLF

RSNHF

SAEX

SALM

SCSC

SEMG

SFDPF

SMHI

SPGYF

SSTI

STTH

SVVC

Stocks That Hit 52-Week Lows On Tuesday

SCANCELL HOLDINGS PLC ORD by Scancell Holdings PLC.

Scancell Holdings PLC

Scancell Holdings

Comments

Scancell Holdings Stock News

News

Latest Scancell Holdings Stock News | OTC:SCNLF | Benzinga

Tuesday, August 27, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga